In contrast, men with a PSA < 20 ng/ml pose a major problem because although only 30–40% of these men will have prostate cancer, all currently undergo potentially unnecessary invasive prostate biopsies to determine who has the disease. This evidence concerns the gene KLK3 and prostate carcinoma.